Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:742 (5 April), doi:10.1136/bmj.39535.488299.DB
Bob Burton
1 Hobart
| The first 150 words of the full text of this article appear below. |
Australias drug industry has said that in the last six months of 2007 alone it organised more than 14 633 "educational events" for the benefit of medical professionals. Detailed monthly reports by 43 companies show that they spent more than $A31m (£14.3m;
18.1m; $28m) and attracted 385 221 people to the events.
Although many meetings were held in hospitals and attracted attendances of only about two dozen, others were more elaborate affairs. Amgen Australia, for example, spent $328 206 on food, alcohol, travel, and accommodation at a Sydney hotel for a two day clinical haematology symposium attended by 142 haematologists and trainees. Amgen sells a range of haematology drugs.
In July 2006 the Australian Competition and Consumer Commission, a government regulatory agency, reauthorised the self regulatory code of conduct developed by Medicines Australia, the major drug industry group.
However, the commission required member companies to submit monthly reports detailing each
What can you learn from this BMJ paper? Read Leanne Tite's Paper+